Latest Medical Discoveries

Ancient DNA suggests Germanic may have reached Scandinavia some 800 years later than assumed

In 1.2 million immune cells, a single-cell model found 48.8% more eGenes than a standard pooled pipeline

Single-nucleus maps of 287 muscle biopsies match almost 3,500 trait signals to regulatory variants

Repeated stretches of DNA shape gene activity immune cell type by cell type, across 1,925 people

A fine-mapping method holds up better than existing tools when the reference panel does not match the study

A map of 12 glioblastomas finds their cells on one path, from development-like states to injury and low oxygen

Coral bacteria make testosterone and progesterone, and giving corals either one shifts their immune genes

State predicts how cells' gene expression responds to perturbation, and flags strong perturbations in cellular contexts where it saw none in training.

After hip or knee replacement, aspirin could not be shown as effective as anticoagulants, nor they as safe as aspirin

A gene circuit keyed to a slip in the ribosome's reading frame makes cancer cells kill themselves in mice

Confirming obesity with waist size, not just BMI, better predicts who faces higher mortality risk

In mice, deleting one immune enzyme eased organ ageing while leaving immune ageing in place

A telomere-to-telomere HG002 benchmark covering the diploid genome's hardest regions

In vivo editing of the PCSK9 gene produced durable cholesterol reductions in an early-stage trial.

The tumour suppressor p53 switches on a cell-cleaning pathway to curb cancer metabolism

Seven genomes from Ethiopia's first Marburg outbreak point to one spillover, then human-to-human spread

Human movement helped drive the early spread of the 2026 Bundibugyo virus outbreak in the Congo

Valve replacement cut combined 2-year death or heart-failure events to 16.7% from 23.9% in at-risk moderate stenosis

Steatohepatitis resolved in over half of patients analysed on each dose of a GLP-1-glucagon drug, vs 13% on placebo

At 10 years, a registry found no detectable survival difference between stents and bypass surgery

A two-drug cancer immunotherapy works by waking dendritic cells, not just T cells, in mice

Cervical cancer killed an estimated 369,000 women in 2023, and deaths are forecast to rise by 2050

In heart-attack shock, intravenous cangrelor was not shown to match crushed ticagrelor on clinical outcomes

A targeted pill shrank PIK3CA-mutated ovarian clear cell tumours in 35% of evaluable trial patients

A personalized neoantigen therapy plus pembrolizumab prolonged recurrence-free survival in a phase 3 melanoma trial

A two-target antibody with chemotherapy shrank tumours in 31 of 42 triple-negative breast cancers

Mass spec measures fluctuation energies for 5,778 protein domains in parallel

Nine trillion base pairs of training, a megabase of context, single-nucleotide resolution.

Ancient-DNA time series reveal hundreds of alleles under directional selection in humans

One model predicts thousands of regulatory genomic tracks and tops specialist tools on variant effects.

A precise single-letter edit reawakens protective fetal hemoglobin without cutting DNA.

After a personalized neoantigen mRNA vaccine, 11 of 14 TNBC patients stayed relapse-free for up to six years

Five genomic factors explain most shared genetic risk across 14 psychiatric disorders

A generative model scaffolds enzyme active sites from functional-group positions alone, no residue order required.

Bimagrumab plus semaglutide produced greater weight loss than either drug alone in a phase 2 trial

A generative model builds active metallohydrolases straight from chemistry, no lab tinkering required.

A single-cell map of bone-innervating sensory neurons identifies FGF9 as a driver of fracture repair

Drug-loaded nanoparticles hijack skull immune cells to bypass the blood-brain barrier for stroke therapy

An open pipeline turns AlphaFold2 into nanomolar binders without high-throughput screening.

High-dimensional profiling reveals how a gene-edited pig organ is rejected, and how it holds.

An in vivo edit of the liver ANGPTL3 gene lowered triglycerides and LDL in a phase 1 trial.

A once-daily small-molecule drug cut body weight by double digits in a large phase 3 obesity trial.

A computational method builds small proteins programmed to recognize chosen DNA targets and control nearby genes.

A language model invented OpenCRISPR-1, a Cas9 hundreds of mutations from anything in nature.

Haplotype-resolved assemblies close most remaining gaps and fully sequence 1,246 centromeres.

A targeted nanoparticle reprograms T cells into cancer fighters, skipping the factory.

Long-term follow-up shows vaccine-induced T cells persist and track with delayed recurrence.

Generative AI builds serine hydrolases with efficiencies approaching natural proteins.

A single infusion of stem-cell-derived islets restored insulin independence in most recipients.

The first personalized in vivo base-editing medicine, from diagnosis to dosing in about six months.